{"id":"https://openalex.org/W4322617331","doi":"https://doi.org/10.1530/etj-23-0003","title":"Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma","display_name":"Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma","publication_year":2023,"publication_date":"2023-02-28","ids":{"openalex":"https://openalex.org/W4322617331","doi":"https://doi.org/10.1530/etj-23-0003","pmid":"https://pubmed.ncbi.nlm.nih.gov/36852694","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10083649"},"language":"en","primary_location":{"id":"doi:10.1530/etj-23-0003","doi":"https://doi.org/10.1530/etj-23-0003","is_oa":true,"landing_page_url":"https://doi.org/10.1530/etj-23-0003","pdf_url":"https://etj.bioscientifica.com/downloadpdf/journals/etj/12/2/ETJ-23-0003.pdf","source":{"id":"https://openalex.org/S2764859698","display_name":"European Thyroid Journal","issn_l":"2235-0640","issn":["2235-0640","2235-0802"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Thyroid Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://etj.bioscientifica.com/downloadpdf/journals/etj/12/2/ETJ-23-0003.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004185196","display_name":"Jo\u00e3o Roque","orcid":"https://orcid.org/0000-0002-1191-4997","observed_orcids":["https://orcid.org/0000-0002-1191-4997"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Jo\u00e3o Roque","raw_affiliation_strings":["Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-1191-4997","affiliations":[{"raw_affiliation_string":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100342129","display_name":"Tiago Silva","orcid":"https://orcid.org/0000-0002-1958-4531","observed_orcids":["https://orcid.org/0000-0002-1958-4531"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Tiago Nunes Silva","raw_affiliation_strings":["Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","NOVA Medical School | Faculdade de Ci\u00eancias M\u00e9dicas of Universidade NOVA de Lisboa, Lisbon, Portugal","Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"NOVA Medical School | Faculdade de Ci\u00eancias M\u00e9dicas of Universidade NOVA de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I83558840"]},{"raw_affiliation_string":"Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035679800","display_name":"Catarina Regala","orcid":"https://orcid.org/0000-0002-0102-4982","observed_orcids":["https://orcid.org/0000-0002-0102-4982"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Catarina Regala","raw_affiliation_strings":["Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101810693","display_name":"Ricardo Rodrigues","orcid":"https://orcid.org/0000-0003-1928-4106","observed_orcids":["https://orcid.org/0000-0003-1928-4106"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ricardo Rodrigues","raw_affiliation_strings":["Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0003-1928-4106","affiliations":[{"raw_affiliation_string":"Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024166264","display_name":"Valeriano Alberto Pais Horta Leite","orcid":"https://orcid.org/0000-0001-5479-7332","observed_orcids":["https://orcid.org/0000-0001-5479-7332"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Valeriano Leite","raw_affiliation_strings":["Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","NOVA Medical School | Faculdade de Ci\u00eancias M\u00e9dicas of Universidade NOVA de Lisboa, Lisbon, Portugal","Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology, Diabetes and Metabolism Department, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"NOVA Medical School | Faculdade de Ci\u00eancias M\u00e9dicas of Universidade NOVA de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I83558840"]},{"raw_affiliation_string":"Unidade Investiga\u00e7\u00e3o Patobiologia Molecular, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5004185196"],"corresponding_institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"],"apc_list":null,"apc_paid":null,"fwci":2.7726,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.9131376,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11728","display_name":"Thyroid and Parathyroid Surgery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/poorly-differentiated-thyroid-carcinoma","display_name":"poorly differentiated thyroid carcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7490000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5950000286102295},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.9150000214576721},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.824999988079071},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9919999837875366},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.949999988079071},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6330000162124634},{"id":"https://openalex.org/keywords/mediastinal-lymph-node-metastasis","display_name":"mediastinal lymph node metastasis","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.9747860431671143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9599895477294922},{"id":"https://openalex.org/C2993294228","wikidata":"https://www.wikidata.org/wiki/Q13632630","display_name":"Thyroid carcinoma","level":3,"score":0.5907676815986633},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.56365966796875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.485087513923645},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.4342820644378662},{"id":"https://openalex.org/C3018694869","wikidata":"https://www.wikidata.org/wiki/Q927316","display_name":"Radioiodine therapy","level":4,"score":0.43243902921676636},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.35383957624435425}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013859","descriptor_name":"Thiocarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013964","descriptor_name":"Thyroid Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1530/etj-23-0003","doi":"https://doi.org/10.1530/etj-23-0003","is_oa":true,"landing_page_url":"https://doi.org/10.1530/etj-23-0003","pdf_url":"https://etj.bioscientifica.com/downloadpdf/journals/etj/12/2/ETJ-23-0003.pdf","source":{"id":"https://openalex.org/S2764859698","display_name":"European Thyroid Journal","issn_l":"2235-0640","issn":["2235-0640","2235-0802"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Thyroid Journal","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10083649","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10083649","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10083649/pdf/ETJ-23-0003.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Thyroid J","raw_type":"Text"},{"id":"pmid:36852694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36852694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European thyroid journal","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4aa4b641c3504e9b9c68a4f2c2eea7f1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4aa4b641c3504e9b9c68a4f2c2eea7f1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Thyroid Journal, Vol 12, Iss 2, Pp 1-7 (2023)","raw_type":"article"},{"id":"pmh:oai:run.unl.pt:10362/153051","doi":null,"is_oa":true,"landing_page_url":"https://www.scopus.com/pages/publications/85158034378","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1530/etj-23-0003","doi":"https://doi.org/10.1530/etj-23-0003","is_oa":true,"landing_page_url":"https://doi.org/10.1530/etj-23-0003","pdf_url":"https://etj.bioscientifica.com/downloadpdf/journals/etj/12/2/ETJ-23-0003.pdf","source":{"id":"https://openalex.org/S2764859698","display_name":"European Thyroid Journal","issn_l":"2235-0640","issn":["2235-0640","2235-0802"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Thyroid Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4322617331.pdf","grobid_xml":"https://content.openalex.org/works/W4322617331.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1965175058","https://openalex.org/W1967792499","https://openalex.org/W2019607817","https://openalex.org/W2031360147","https://openalex.org/W2037395633","https://openalex.org/W2062175236","https://openalex.org/W2168076926","https://openalex.org/W2408861454","https://openalex.org/W2766426751","https://openalex.org/W2914407722","https://openalex.org/W2999089687","https://openalex.org/W3015023711","https://openalex.org/W3042946930","https://openalex.org/W3083074269","https://openalex.org/W3126391719","https://openalex.org/W3179200118","https://openalex.org/W4213345155","https://openalex.org/W4220921210","https://openalex.org/W4224213176","https://openalex.org/W4233041872","https://openalex.org/W4233923946","https://openalex.org/W4240615046","https://openalex.org/W4255292957","https://openalex.org/W4299595272","https://openalex.org/W6684581418","https://openalex.org/W6798171718"],"related_works":["https://openalex.org/W4393035962","https://openalex.org/W3015023711","https://openalex.org/W2766426751","https://openalex.org/W3126391719","https://openalex.org/W4411151691","https://openalex.org/W3083074269","https://openalex.org/W3017338478","https://openalex.org/W4286298673","https://openalex.org/W4412751500","https://openalex.org/W2996749329"],"abstract_inverted_index":{"Background":[0],"and":[1,29,58,73,137,149,154,167,182,192,200,215,247,252],"objective:":[2],"Lenvatinib":[3,222,234],"showed":[4,127],"promising":[5],"results":[6],"in":[7,18,33,51,78,115,152,225],"a":[8,52,97],"subgroup":[9],"of":[10,31,36,42,75,91,93,100,102,117,171,245],"patients":[11,45,86,120,126,204,227],"with":[12,46,49,146],"poorly":[13],"differentiated":[14],"thyroid":[15],"carcinoma":[16],"(PDTC)":[17],"the":[19,27,79,168],"SELECT":[20],"trial.":[21],"Our":[22],"aim":[23],"was":[24,113,144,164,173,179,186,197,223],"to":[25,160,229],"report":[26],"effectiveness":[28],"tolerability":[30,251],"lenvatinib":[32,50,92],"our":[34],"series":[35],"PDTC":[37,47,67,85,241],"patients.":[38,118,242],"Methods:":[39],"Medical":[40],"records":[41],"eight":[43],"consecutive":[44],"treated":[48],"single":[53],"center":[54],"between":[55],"January":[56],"2019":[57],"October":[59],"2022":[60],"were":[61,66],"retrospectively":[62],"reviewed.":[63],"Inclusion":[64],"criteria":[65,72],"diagnosis":[68],"based":[69],"on":[70],"Turin":[71],"evidence":[74],"disease":[76,141,151],"progression":[77],"previous":[80],"6":[81],"months.":[82,104,175],"Results:":[83],"Eight":[84],"received":[87],"an":[88,236],"average":[89],"dose":[90,213,254],"18.1":[94],"mg":[95],"for":[96,239],"median":[98,158,169,183],"duration":[99,170],"treatment":[101,220,238,250],"10.3":[103],"The":[105,140,157],"baseline":[106],"Eastern":[107],"Cooperative":[108],"Oncology":[109],"Group":[110],"performance":[111],"status":[112],"\u22652":[114],"50%":[116],"Two":[119],"had":[121,212,218],"unresectable":[122],"primary":[123],"tumor.":[124],"Seven":[125],"extrathyroidal":[128],"disease,":[129],"particularly":[130],"mediastinal":[131],"lymph":[132],"nodes":[133],"(85.7%),":[134],"lung":[135],"(71.4%),":[136],"bone":[138],"(71.4%).":[139],"control":[142],"rate":[143],"100%,":[145],"partial":[147],"response":[148,163,172],"stable":[150],"12.5":[153],"87.5%,":[155],"respectively.":[156,202],"time":[159],"best":[161],"overall":[162,184,195],"3":[165],"months,":[166,194],"7.5":[174],"Median":[176],"progression-free":[177],"survival":[178,185,196],"12":[180],"months":[181],"not":[187],"reached.":[188],"At":[189],"6,":[190],"12,":[191],"18":[193],"87.5,":[198],"71.4,":[199],"57.1%,":[201],"All":[203],"experienced":[205],"drug-related":[206],"adverse":[207],"effects":[208],"(AEs).":[209],"Four":[210],"(50%)":[211],"reductions":[214],"two":[216,226],"(25%)":[217],"temporary":[219],"interruptions.":[221],"stopped":[224],"due":[228],"grade":[230],"\u22653":[231],"AEs.":[232],"Conclusion:":[233],"is":[235],"effective":[237],"real-world":[240],"Adequate":[243],"management":[244],"comorbidities":[246],"AEs":[248],"increases":[249],"minimizes":[253],"reductions.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-03-01T00:00:00"}
